SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-21-045052
Filing Date
2021-08-26
Accepted
2021-08-26 16:31:13
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea146433-f1_canfite.htm F-1 416274
2 OPINION OF DORON, TIKOTZKY, KANTOR, GUTMAN, NASS, AMIT GROSS AND CO., ISRAELI CO ea146433ex5-1_canfite.htm EX-5.1 28709
3 FORM OF PLACEMENT AGENT WARRANT ISSUED BY CAN-FITE BIOPHARMA LTD. ON AUGUST 16, ea146433ex10-30_canfite.htm EX-10.30 124549
4 CONSENT OF KOST FORER GABBAY & KASIERER ea146433ex23-1_canfite.htm EX-23.1 3224
5 GRAPHIC image_001.jpg GRAPHIC 7125
6 GRAPHIC image_002.jpg GRAPHIC 7125
7 GRAPHIC ex5-1_001.jpg GRAPHIC 5624
  Complete submission text file 0001213900-21-045052.txt   601575
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-259085 | Film No.: 211212746
SIC: 2834 Pharmaceutical Preparations